New heart drug SHR-6934 put to the test in healthy people
NCT ID NCT06700083
First seen May 11, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This early-stage study is testing a new drug called SHR-6934, given as an injection under the skin, to see if it is safe and how the body processes it. The study involves 88 healthy adults aged 18 to 60. Researchers are monitoring for side effects and measuring drug levels in the blood. This is a first step before testing the drug in people with heart failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.